September 22, 2020
PA-19-029 - Innovation Corps (I-Corps™) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)
National Cancer Institute (NCI)
The purpose of this Notice is to inform potential applicants that two sets of cohort dates are scheduled in FY2021 for PA-19-029, “Innovation Corps (I-Corps™) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed).” This notice also informs all potential applicants that all required workshops of the program will be conducted virtually. No travel is needed for kick-off and closing workshop events.
The following changes and updates are made to PA-19-029 (shown in italics) to reflect cohort dates and venues for FY2021 in this FOA:
Part 2. Full Text of Announcement, Section I. Funding Opportunity Description, Program Description
Currently reads:
Details for the FY2019 cohorts are given below. All team members accepted to the I-Corps at NIH are required to participate in each of the program events given below. Additional dates will be released by Notice.
Modified to read (in italics):
Details for the FY2021 cohorts are given below. All team members accepted to the I-Corps at NIH are required to participate in each of the program events given below.
Table Modified to read (in italics):
Application Due Date |
November 17, 2020 |
February 2, 2021 |
Phone Interview |
January 5-6, 2021 (estimated) |
March 9-11, 2021 (estimated) |
Kick-off/Close-out Venue |
Online |
Online |
Course Kick-off |
February 22-25, 2021 (Monday - Thursday) |
May 24-27, 2021 (Monday - Thursday) |
Web-Ex Courses |
Wednesdays, 1-5PM ET March 3 March 10 March 17 March 24 March 31 April 7 |
Wednesdays, 1-5PM ET June 2 June 9 June 16 June 23 June 30 July 7 |
Course Close-out/ Lessons-Learned |
April 12-13, 2021 (Monday - Tuesday) |
July 12-13, 2021 (Monday-Tuesday) |
Cohort Size |
24 teams |
24 teams |
Currently reads:
Entrepreneurial Immersion
The I-Corps curriculum provides real-world, hands-on, immersive learning about what it takes to successfully translate promising technologies into products or services that will benefit society. At the beginning of the training program, I-Corps team members will be required to attend an evening reception plus an intensive, 3-day kick-off Entrepreneurial Immersion course together (exact location to be announced). After the 3-day Entrepreneurial Immersion course, I-Corps teams will return to their home institutions for 6 weeks and will be required to conduct customer discovery activities as well as participate in weekly web-based conference meetings with the instructors. In addition, it is expected that I-Corps teams will take advantage of instructor office hours. At the completion of the course, I-Corps teams must also attend a 2-day final Course Close-out/Lessons-Learned workshop (anticipated Washington, DC area).
Modified to read (in italics):
The I-Corps curriculum provides real-world, hands-on, immersive learning about what it takes to successfully translate promising technologies into products or services that will benefit society. At the beginning of the training program, I-Corps team members will be required to attend an evening reception plus an intensive, 3-day kick-off Entrepreneurial Immersion course together (online). After the 3-day Entrepreneurial Immersion course, I-Corps teams over the following 6 weeks will be required to conduct customer discovery activities as well as participate in weekly web-based conference meetings with the instructors. In addition, it is expected that I-Corps teams will take advantage of instructor office hours. At the completion of the course, I-Corps teams must also attend a 2-day final Course Close-out/Lessons-Learned workshop (online).
Section IV. Application and Submission Information
Currently reads:
(A) a kick-off evening reception plus a three-day grantee entrepreneurial immersion workshop (city and venue to be determined), followed, approximately six weeks later, by
(B) a two-day course Close Out/Lessons Learned workshop at the end of the course (city and venue to be determined).
Modified to read (in italics):
Christie A. Canaria, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5720
Email:[email protected]